| 
                                                
                                                  External radiation delivered from a high energy X-ray machine called a linear accelerator has been
                                                   effectively used to treat prostate cancer for more than 30 years. In recent years, there have been several major technological
                                                   advances allowing cure rates that typically exceed those of surgery and proton beam therapy, with far fewer side effects.  
                                                 
                                                  
                                                 With intensity modulated radiation therapy (IMRT), sophisticated computers modulate the intensity
                                                   of the radiation beam, increasing it to areas where cancer cells reside, and decreasing it to areas that need to be protected.
                                                   This allows for maximum radiation to be delivered to the prostate and areas potentially harboring cancer cells, while minimizing
                                                   radiation to the bladder and rectum. Patients with intermediate to advanced stage prostate cancer have a high risk of having
                                                   cancer outside the prostate, beyond the surgeon's reach. Unlike surgery, IMRT can treat this area.  
                                                 
                                                 With intensity modulated radiation therapy (IMRT), sophisticated computers modulate the intensity
                                                   of the radiation beam, increasing it to areas where cancer cells reside, and decreasing it to areas that need to be protected.
                                                   This allows for maximum radiation to be delivered to the prostate and areas potentially harboring cancer cells, while minimizing
                                                   radiation to the bladder and rectum. Patients with intermediate to advanced stage prostate cancer have a high risk of having
                                                   cancer outside the prostate, beyond the surgeon's reach. Unlike surgery, IMRT can treat this area.  
                                                 
                                                  
                                                
                                                  
                                                 Image Guided Radiation Therapy (IGRT) takes IMRT one step further. Various imaging technologies such
                                                   as Cone-beam ® CT scan and tracking of implanted gold fiducial markers are utilized before each daily treatment, to acquire
                                                   a 3-dimensional image of the prostate and surrounding anatomy. Computers detect any slight change in position of the prostate
                                                   gland that may result from movement or variations in filling of the bladder or rectum. Using this information, the computer
                                                   adjusts the radiation beam accordingly in order to precisely target the treatment to the prostate's exact position that day.
                                                   Changes as small as 1 millimeter are made to provide the greatest precision available. IGRT is the newest and most advanced
                                                   system for the delivery of radiation, allowing much greater precision than proton therapy.  
                                                 
                                                 We are one of the only centers in the world doing MRI treatment planning for prostate cancer. Prior to
                                                   beginning IGRT treatment, our patients undergo this special MRI scan and a CT scan in our department. The information from
                                                   the 2 scans in entered into our specialized computers and a customized treatment plan is created, tailored to fit each patient's
                                                   anatomy precisely. IGRT is typically given for only a few minutes a day, five days a week. When combined with a seed implant,
                                                   this part of the treatment is approximately 5 weeks long. If given without a seed implant, the treatment is typically for
                                                   8 1/2 weeks. IGRT is completely painless and non-invasive. The most commonly reported side effects during
                                                   treatment are slight fatigue and having to go to the bathroom more frequently. You will NOT develop any nausea, abdominal
                                                   pain, hair loss, or skin burning. You will NOT lose your ability to control your bowels or bladder. You will be able to continue
                                                   working full-time and should enjoy all of your regular activities. 
                                                 
                                                  
                                                
                                                   
                                                   	    
                                                      
                                                         | 
                                                             Why is IMRT / IGRT better than Protons- Increased dose conformality with IMRT vs. Protons
 - Smaller
                                                               volume of normal tissue around the prostate treated to high doses
 - Less uncertainty in dose deposition
 - Lower
                                                               volumes of normal tissue treated to high doses
 - More sophisticated image guidance with 3D volumetric instead of planar
                                                               images
 - Potential rectal sparing due to the air in the rectal balloon
 - Superior clinical results
 
  
                                                               
                                                             
                                                          | 
                                                       
                                                    
                                                   
                                                
                                                
                                                High Dose Radiation Outcomes (Viani et al IJROBP
                                                   2009)    
                                                 
                                                
                                                   
                                                   	    
                                                      
                                                         |   | 
                                                         
                                                            
                                                          | 
                                                         
                                                            
                                                          | 
                                                       
                                                      
                                                         | 
                                                            
                                                          | 
                                                         
                                                            T1c-T2a, Gleason ≤6, and PSA <10  
                                                          | 
                                                         
                                                            
                                                          | 
                                                       
                                                      
                                                         | 
                                                            
                                                          | 
                                                         
                                                            T2b or Gleason 7 or PSA 10-20  
                                                          | 
                                                         
                                                            
                                                          | 
                                                       
                                                      
                                                         | 
                                                             High risk  
                                                          | 
                                                         
                                                            T2c-T3, Gleason 8-10, or PSA ≥20  
                                                          | 
                                                         
                                                            
                                                          | 
                                                       
                                                    
                                                   
                                                
                                              |